釋放劑試管檢測(cè)法套裝

廣州健侖生物科技有限公司

（廣州健侖生物科技有限公司是集研制開(kāi)發(fā)、銷售、服務(wù)于一體的優(yōu)良企業(yè),公司產(chǎn)品涉及臨床快速診斷試劑、食品安全檢測(cè)試劑，違禁品快速檢測(cè)，動(dòng)物疾病防疫檢測(cè)試劑，免疫診斷試劑、臨床血液學(xué)和體液學(xué)檢驗(yàn)試劑、微生物檢驗(yàn)試劑、分子生物學(xué)檢驗(yàn)試劑、臨床生化試劑、有機(jī)試劑等眾多領(lǐng)域，同時(shí)核心代理Panbio、FOCUS、Qiagen、IBL、CORTEZ、Fuller、Inbios、BinaxNOW、LumuQuick、日本富士、日本生研等多家有名診斷產(chǎn)品集團(tuán)公司產(chǎn)品，致力于為商檢單位、疾病預(yù)防控制中心、海關(guān)出入境檢疫局、衛(wèi)生防疫單位,緝毒系統(tǒng)，戒毒中心，檢驗(yàn)檢疫單位、生化企業(yè)、科研院所、醫(yī)療機(jī)構(gòu)等機(jī)構(gòu)與行業(yè)提供*、高品質(zhì)的產(chǎn)品服務(wù)。此外，本公司還開(kāi)展食品、衛(wèi)生、環(huán)境、藥品等多方面的第三方檢測(cè)服務(wù)。）

【產(chǎn)品名稱】樣本釋放劑

【包裝規(guī)格】20測(cè)試/盒 （溶液I:20×1 Test/瓶；溶液II:20 Test/瓶）         □

50測(cè)試/盒 （溶液I:50×1 Test/瓶；溶液II:50 Test/瓶X 1 ）    □

             100測(cè)試/盒 （溶液I:100×1 Test/瓶；溶液II:50 Test/瓶X 2）   □

【預(yù)期用途】

用于待測(cè)致敏紅細(xì)胞樣本的預(yù)處理，使致敏紅細(xì)胞樣本中的待測(cè)抗體從與細(xì)胞結(jié)合的狀態(tài)中解離釋放出來(lái)。以便于使用體外診斷試劑或儀器對(duì)待測(cè)抗體進(jìn)行檢測(cè)。

【檢驗(yàn)原理】

紅細(xì)胞上的抗原與血清中抗體在適合條件下發(fā)生致敏，這種結(jié)合在一定條件下是可逆的。將已致敏的紅細(xì)胞懸浮于低pH值的甘氨酸溶液中，抗體蛋白又可以從結(jié)合的紅細(xì)胞上解離釋放出來(lái)。離心取上清解離的放散液，此液中含有從紅細(xì)胞表面解離釋放出來(lái)的抗體蛋白，經(jīng)Tris緩沖液調(diào)節(jié)pH至中性后此上清放散液可用于相關(guān)抗體的檢測(cè)和鑒定；而解離釋放后的紅細(xì)胞經(jīng)洗滌后可用于血型定型、自身抗體的吸收等。

【主要組成成份】

1.溶液I：主要組分為甘氨酸(C₂H₅NO₂)，氯化鈉(NaCl)。

2.溶液II：主要組分為Tris堿，指示劑。   

【儲(chǔ)存條件及有效期】                  

常溫（10～30℃）儲(chǔ)存，有效期1年。試劑開(kāi)瓶后在常溫（10～30℃）條件下可儲(chǔ)存6個(gè)月。

【樣本要求】

新鮮或2～8℃保存不超過(guò)72小時(shí)的抗凝血樣。

釋放劑試管檢測(cè)法套裝

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲、恙蟲、利什曼原蟲、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

【產(chǎn)品介紹】

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

生長(zhǎng)激素（Somatropin）為DNA重組人生長(zhǎng)激素，具有人體生長(zhǎng)激素同等作用。能促進(jìn)骨骼、內(nèi)臟和全身生長(zhǎng)．促進(jìn)蛋白質(zhì)合成，影響脂肪和礦物質(zhì)代謝，在人體生長(zhǎng)發(fā)育中起著關(guān)鍵性作用。皮下注射約80%被吸收，5小時(shí)達(dá)血藥濃度高峰，半衰期為4小時(shí)。注射劑量的90%在肝臟代謝，僅約0.1%以原形由膽道、腎臟排泄。主要用于內(nèi)源性垂體生長(zhǎng)激素分泌不足而引起的生長(zhǎng)障礙、軀體矮小的侏儒癥、矮小病患兒。尚可用于治療燒傷、骨折、創(chuàng)傷、出血性潰瘍、肌肉萎縮癥、骨質(zhì)疏松等疾病。
促性腺激素（gonadotropins, Gn）是調(diào)節(jié)脊椎動(dòng)物性腺發(fā)育，促進(jìn)性激素生成和分泌的糖蛋白激素。如垂體前葉分泌的促黃體生成激素（LH）和促卵泡成熟激素（FSH），兩者協(xié)同作用，刺激卵巢或睪丸中生殖細(xì)胞的發(fā)育及性激素的生成和分泌；人胎盤分泌的絨毛膜促性腺激素（HCG），可促進(jìn)妊娠黃體分泌孕酮。懷孕初期尿中即可出現(xiàn)HCG，于妊娠兩個(gè)月時(shí)達(dá)高峰，臨床常以此作為妊娠指標(biāo)。促性腺激素（LH，F(xiàn)SH，HCG）與促甲狀腺激素（TSH）均由α及β兩條肽鏈通過(guò)非共價(jià)鍵組合而成，
垂體促性腺激素的生成和釋放受下丘腦促黃體生成激素釋放激素（LH－RH）的直接調(diào)控。LH與FSH的靶腺產(chǎn)物——性激素反過(guò)來(lái)也可影響垂體或下丘腦的分泌功能。病毒此LH－RH、LH與FSH以及性激素的分泌相互制約，起伏頗有節(jié)奏。女性月經(jīng)周期的反復(fù)出現(xiàn)就是這三級(jí)激素分泌的起伏和節(jié)律性變病毒的結(jié)果。
LH又稱促間質(zhì)細(xì)胞激素（ICSH），病毒為它作用于睪丸的間質(zhì)細(xì)胞，刺激雄性激素的生成和分泌。LH對(duì)雌性動(dòng)物卵巢的主要作用為選擇性誘導(dǎo)排卵前的個(gè)別卵泡迅速長(zhǎng)大，待LH的分泌達(dá)高潮時(shí)，觸發(fā)排卵并使排卵后的卵泡壁轉(zhuǎn)病毒為黃體及分泌孕酮。FSH的重要作用是促進(jìn)卵巢中卵泡的生長(zhǎng)和發(fā)育，在雄性則促進(jìn)睪丸曲細(xì)精管中精子的生成。
從動(dòng)物垂體制取的促性腺激素，已廣泛應(yīng)用于畜牧、水產(chǎn)業(yè)，但對(duì)人類無(wú)效。從孕婦尿中可制取HCG，或從絕經(jīng)期婦女尿中提取LH與FSH的混合制劑，簡(jiǎn)稱人絕經(jīng)期促性腺激素（HMG），臨床上可用于治療性功能減退癥。

Somatropin is a DNA recombinant human growth hormone that has the same effect as human growth hormone. Can promote bone, internal organs and body growth. Promote protein synthesis, affect fat and mineral metabolism, play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours reached the peak plasma concentration, half-life of 4 hours. Ninety percent of the injected dose is metabolized in the liver and only about 0.1% is excreted by the biliary tract and the kidneys in its original form. Mainly used for endogenous pituitary growth hormone secretion caused by lack of growth disorders, dwarf dwarfism, dwarfism. Still can be used to treat burns, fractures, trauma, hemorrhagic ulcer, muscular dystrophy, osteoporosis and other diseases.
Gonadotropins (Gn) are glycoprotein hormones that regulate vertebrate gonadal development and promote the production and secretion of sex hormones. Such as the secretion of the anterior pituitary luteinizing hormone (LH) and follicle-stimulating hormone (FSH), both synergistic effect to stimulate ovarian or testicular germ cell development and sex hormone production and secretion; human placental secretion of chorionic Hormone (HCG), progesterone can promote the secretion of luteal pregnancy. HCG in early pregnancy can occur in urine, peaked at two months of pregnancy, clinically used as a pregnancy index. Both gonadotropins (LH, FSH, HCG) and thyrotropin (TSH) are composed of non-covalently linked two peptide chains of α and β,
The production and release of pituitary gonadotropin is directly regulated by hypothalamic luteinizing hormone releasing hormone (LH-RH). The target gland products LH and FSH - sex hormones can also affect the secretion of pituitary or hypothalamus. Virus LH-RH, LH and FSH and the secretion of sex hormones mutual constraints, ups and downs quite rhythm. The recurrence of the female menstrual cycle is the result of fluctuations and rhythmic variations in the secretion of these three hormones.
LH, also known as the so-called stromal cell hormone (ICSH), the virus acts on the testicular interstitial cells to stimulate the production and secretion of male hormones. The main role of LH in the ovary of female animals is to selectively induce the rapid growth of individual ovarian follicles before ovulation. When the secretion of LH reaches orgasm, it triggers ovulation and turns the ovarian follicular wall virus into corpus luteum and progesterone secretion. The important role of FSH is to promote ovarian follicle growth and development in the male while promoting the testicular seminiferous tubule sperm production.
Gonadotropins made from animal pituitary gland, has been widely used in animal husbandry, aquaculture, but not for humans. HCG can be obtained from the urine of pregnant women, or from the urine of menopausal women to extract LH and FSH mixed preparation, referred to as human menopause gonadotropin (HMG), clinically useful for the treatment of hypogonadism.